X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2399) 2399
Publication (301) 301
Book Review (21) 21
Book Chapter (18) 18
Magazine Article (14) 14
Dissertation (4) 4
Web Resource (4) 4
Conference Proceeding (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1441) 1441
malaria (1335) 1335
index medicus (1295) 1295
artemether (1284) 1284
artemether-lumefantrine (1004) 1004
female (812) 812
male (808) 808
tropical medicine (792) 792
antimalarials - therapeutic use (764) 764
infectious diseases (742) 742
parasitic diseases (705) 705
parasitology (704) 704
animals (640) 640
malaria, falciparum - drug therapy (631) 631
artesunate (572) 572
artemisinin (546) 546
research (532) 532
artemisinins - therapeutic use (525) 525
adult (515) 515
child, preschool (512) 512
plasmodium falciparum (508) 508
child (490) 490
drug combinations (459) 459
children (451) 451
drug resistance (445) 445
pharmacology & pharmacy (443) 443
adolescent (429) 429
infant (410) 410
antimalarials - administration & dosage (407) 407
plasmodium falciparum - drug effects (405) 405
malaria - drug therapy (402) 402
antimalarials (399) 399
drug therapy (370) 370
antimalarials - pharmacology (359) 359
artemisinins - administration & dosage (352) 352
plasmodium-falciparum malaria (351) 351
efficacy (333) 333
artemisinins (328) 328
drug therapy, combination (323) 323
parasites (316) 316
treatment outcome (314) 314
infectious and parasitic diseases (306) 306
public, environmental & occupational health (295) 295
public health (290) 290
arctic medicine. tropical medicine (289) 289
drugs (289) 289
middle aged (286) 286
vector-borne diseases (282) 282
malaria, falciparum - parasitology (280) 280
health aspects (276) 276
microbiology (263) 263
chloroquine (262) 262
dihydroartemisinin (262) 262
fluorenes - therapeutic use (248) 248
pharmacokinetics (248) 248
plasmodium-falciparum (244) 244
young adult (243) 243
sulfadoxine-pyrimethamine (241) 241
lumefantrine (237) 237
analysis (236) 236
ethanolamines - therapeutic use (231) 231
artemisinins - pharmacology (227) 227
antimalarials - adverse effects (225) 225
resistance (222) 222
care and treatment (221) 221
plasmodium falciparum - genetics (217) 217
amodiaquine (212) 212
mefloquine (211) 211
antimalarials - pharmacokinetics (209) 209
medicine (205) 205
sesquiterpenes - therapeutic use (203) 203
dihydroartemisinin-piperaquine (197) 197
uncomplicated malaria (196) 196
infections (193) 193
artemisinins - adverse effects (186) 186
quinine (185) 185
studies (182) 182
in-vitro (177) 177
mice (171) 171
combination therapy (166) 166
drug dosages (163) 163
malaria, falciparum - epidemiology (162) 162
erythrocytes (159) 159
safety (158) 158
clinical trials (157) 157
africa (154) 154
research article (154) 154
plasmodium falciparum - isolation & purification (149) 149
polymerase chain reaction (147) 147
dosage and administration (146) 146
fluorenes - administration & dosage (144) 144
combination (143) 143
human diseases (143) 143
medical research (141) 141
pregnancy (141) 141
aged (137) 137
usage (137) 137
artemisinins - pharmacokinetics (136) 136
ethanolamines - administration & dosage (135) 135
pharmacology (134) 134
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2368) 2368
French (34) 34
Chinese (10) 10
German (7) 7
Japanese (5) 5
Spanish (4) 4
Portuguese (3) 3
Turkish (2) 2
Croatian (1) 1
Malay (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 06/2017, Volume 61, Issue 6
Journal Article
PLoS Medicine, ISSN 1549-1277, 06/2018, Volume 15, Issue 6, p. e1002579
Background The fixed dose combination of artemether-lumefantrine (AL) is the most widely used treatment for uncomplicated Plasmodium falciparum malaria.... 
MEDICINE, GENERAL & INTERNAL | EFFICACY | BENFLUMETOL | POPULATION PHARMACOKINETICS | SULFADOXINE-PYRIMETHAMINE | UGANDAN CHILDREN | RANDOMIZED-TRIAL | UNCOMPLICATED MALARIA | THERAPEUTIC RESPONSE | PLASMODIUM-FALCIPARUM MALARIA | CLINICAL-RESPONSE | Ethanolamines - pharmacology | Fluorenes - pharmacokinetics | Malaria, Falciparum - drug therapy | Antimalarials - pharmacokinetics | Models, Chemical | Humans | Child, Preschool | Infant | Male | Antimalarials - therapeutic use | Fluorenes - pharmacology | Artemether, Lumefantrine Drug Combination - pharmacology | Antimalarials - pharmacology | Dose-Response Relationship, Drug | Pregnancy | Ethanolamines - pharmacokinetics | Artemether, Lumefantrine Drug Combination - pharmacokinetics | Ethanolamines - metabolism | Female | Artemether, Lumefantrine Drug Combination - therapeutic use | Fluorenes - metabolism | Infant, Newborn | Plasmodium falciparum | Medical research | Usage | Plasma physics | Metabolites | Malaria | Pregnant women | Medicine, Experimental | Drug therapy | Development and progression | Care and treatment | Health aspects | Health care | Schedules | Tablets | Systematic review | Epidemiology | Maternal & child health | Search engines | Children | Pretreatment | Drug dosages | Age | Dihydroartemisinin | Vector-borne diseases | Dosing | Computer simulation | Exposure | Pharmacology | Bioavailability | Patients | Computer programs | Medicine | Scientific papers | Hospitals | Womens health | Pharmacy | Artemether | Adults | Life Sciences | Santé publique et épidémiologie | Hälsovetenskaper | Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi | Medical and Health Sciences | Medicin och hälsovetenskap | Public Health, Global Health, Social Medicine and Epidemiology | Health Sciences
Journal Article
03/2014
Artemether–Lumefantrine (ALu) is widely used for uncomplicated malaria during the second and third trimester of pregnancy. Because of the suspected teratogenic... 
pregnant women | Tanzania | Artemether | malaria | lumefantrine | dispensers
Web Resource
Malaria Journal, ISSN 1475-2875, 05/2019, Volume 18, Issue 1, pp. 180 - 180
Journal Article
MALARIA JOURNAL, ISSN 1475-2875, 10/2018, Volume 17, Issue 1, pp. 369 - 10
BackgroundArtemisinin-based combination therapy (ACT) is the first-line anti-malarial treatment of uncomplicated malaria in most malaria endemic countries,... 
INFECTIOUS DISEASES | Malaria | Piperaquine | ARTEMETHER-LUMEFANTRINE | Artemisinin | Tanzania | Efficacy | PREVALENCE | PLASMODIUM-FALCIPARUM MALARIA | TROPICAL MEDICINE | CHILDREN | Molecular markers | POLYMORPHISMS | DIHYDROARTEMISININ-PIPERAQUINE | UNCOMPLICATED MALARIA | PROVINCES | Safety | MULTIDRUG-RESISTANCE | Artemisinin-based combination therapy | ASSOCIATION | PARASITOLOGY | Antimalarials - adverse effects | Malaria, Falciparum - prevention & control | Artemether, Lumefantrine Drug Combination - adverse effects | Prospective Studies | Humans | Child, Preschool | Infant | Male | Antimalarials - therapeutic use | Plasmodium falciparum - drug effects | Artemisinins - therapeutic use | Adolescent | Amodiaquine - adverse effects | Female | Quinolines - therapeutic use | Amodiaquine - therapeutic use | Artemether, Lumefantrine Drug Combination - therapeutic use | Artemisinins - adverse effects | Child | Drug Combinations | Quinolines - adverse effects | Research | Drug therapy | Analysis | Public health law | Therapy | Protocols | Endemic species | Countries | Erythrocytes | Parasites | Acquired immune deficiency syndrome--AIDS | Artesunate | Public health | Dihydroartemisinin | Vector-borne diseases | Mutations | Human diseases | Nucleotide sequence | Patients | Mutants | Polymerase chain reaction | Studies | Samples | DNA | Organizations | Alleles | Amodiaquine | Artemether | Mutation | provinces | Parasitology | dihydroartemisinin-piperaquine | association | Klinisk medicin | plasmodium-falciparum malaria | polymorphisms | Clinical Medicine | prevalence | artemether-lumefantrine | multidrug-resistance | children | uncomplicated malaria | Infectious Diseases | Tropical Medicine
Journal Article
MALARIA JOURNAL, ISSN 1475-2875, 07/2018, Volume 17, Issue 1, pp. 261 - 11
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 11/2018, Volume 179, Issue 5, pp. 1225 - 1226
Journal Article
03/2010
Purpose: Nigeria has adopted quinine as the drug of first choice in the treatment of severe malaria and artemether as an alternative therapy. The purpose of... 
Nigerian children | Paediatric | Severe malaria | Artemether | Quinine
Web Resource
MALARIA JOURNAL, ISSN 1475-2875, 06/2018, Volume 17, Issue 1, pp. 222 - 14
Journal Article
MALARIA JOURNAL, ISSN 1475-2875, 06/2018, Volume 17, Issue 1, pp. 223 - 11
Journal Article
MALARIA JOURNAL, ISSN 1475-2875, 07/2018, Volume 17, Issue 1, pp. 258 - 8
Journal Article
11/2012
Purpose: To assess the knowledge and awareness of pregnant women regarding the use of sulfadoxinepyrimethamine (SP) for intermittent preventive therapy (IPT)... 
Pregnant women | Sulfadoxinepyrimethamine | Antenatal clinic | Knowledge | Artemether-lumefantrine
Web Resource
08/2012
Purpose: To develop and validate a dissolution test method for dissolution release of artemether and lumefantrine from tablets. Methods: A single dissolution... 
Lumefantrine | Artemether | Single dissolution test | Tablet formulations | HPLC
Web Resource
The Journal of infectious diseases, ISSN 0022-1899, 12/2018, Volume 220, Issue 4, pp. 687 - 698
Gut microbiota were recently shown to impact malaria disease progression and outcome, and prior studies have shown that Plasmodium infections increase the... 
microbiota | Major and Brief Reports | infants | artemether | malaria | antibiotics | lumefantrine
Journal Article